Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Exhaled carbon monoxide in lung disease Source: Eur Respir J 2003; 21: 197 Year: 2003
Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005
Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Exhaled carbon monoxide in patients with bronchiolitis obliterans after lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Source: Eur Respir J 2002; 20: 92-99 Year: 2002
Exhaled carbon monoxide in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004
Exhaled carbon monoxide levels during treatment of acute asthma Source: Eur Respir J 2001; 17: 1336 Year: 2001
Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003
The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006
Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017
Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Exhaled carbon monoxide in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007